By Sweet Natured Pet | Flea & Tick Safety, Pet Wellness

You love your dog. You follow your vet's advice. You pick up that monthly chewable or spot-on treatment without much thought — because that's what responsible pet parents do, right?

We get it. We've been there.

But here's what the packaging doesn't tell you: many of the most popular flea and tick preventatives on the market come with a side effects list that would make most people pause — if they knew about it. Some carry formal FDA warnings. Some have generated more incident reports than any other EPA-regulated pet product in history. And some raise questions that regulators themselves haven't fully answered.

This isn't about fear. It's about being informed — because you can't make the best choice for your family without the full picture.

Let's take a closer look.

---

 

The Big Players — and What's Inside Them

There are three main categories of conventional flea and tick prevention. Each works differently. Each carries its own risk profile.

 

Oral Chewables: Isoxazoline-Based Medications

These are the prescription-strength monthly (or quarterly) chewables that have become incredibly popular in the last decade. They work by circulating an insecticide called an isoxazoline through your dog's bloodstream — so when a flea or tick bites, they get a lethal dose.

In September 2018, the FDA issued a formal alert warning pet owners and veterinarians about neurologic adverse events associated with all products in the isoxazoline class. The active ingredients under scrutiny include afoxolaner, fluralaner, sarolaner, and lotilaner — found in several widely prescribed oral flea and tick medications. Post-marketing data showed that some dogs were experiencing muscle tremors, loss of coordination (ataxia), and seizures.

Most significantly: the FDA noted that seizures may occur in animals with no prior history of neurological issues. These weren't just dogs who were already at risk. Product labels for medications containing these active ingredients now carry specific neurological warnings — including convulsions, ataxia, and muscle tremor in previously healthy animals.

The FDA's current position is that isoxazoline-class products are "safe and effective for the majority of animals" — but acknowledges that individual risk must be weighed on a pet-by-pet basis.

---

The Seresto Collar: Imidacloprid + Flumethrin

The Seresto collar promised something appealing: eight months of hands-off protection. No monthly applications, no pills. Just clip it on and forget it.

The problem is what happens when you forget about it.

Since the collar went on the market in 2012, the EPA has received more than 105,000 incident reports linked to Seresto — including over 3,000 reported pet deaths. That's more incident reports than any other EPA-regulated pet product in history.

To be fair, the manufacturer and the EPA both maintain the collar is safe when used as directed. And not every incident report proves direct causation — many lack the clinical detail to draw firm conclusions. But the volume and consistency of reports prompted a Congressional investigation.

A U.S. House subcommittee found that the collar ranked #1 by a wide margin in total incidents, major incidents, and deaths compared to similar products — even when adjusted for how many collars were sold. Canada's equivalent of the EPA reviewed the same American data and ultimately banned the collar, determining it posed too great a risk to pets and their owners.

Meanwhile, a February 2024 report from the EPA's own Office of Inspector General found that the agency had failed to conduct the animal risk assessments it promised to perform, and continues to rely on a 1998 companion animal safety study to make decisions about a product launched in 2012. The OIG's conclusion: it's impossible to say with confidence whether the collar can be used safely.

A $15 million class action settlement was approved in early 2024 — though many affected pet owners called that amount a drop in the bucket compared to what they experienced.

Reported adverse effects include skin lesions, seizures, lethargy, vomiting, abnormal behavior, and in some cases, death.

 

---

Liquid Topicals: Permethrin + Imidacloprid

Liquid topical treatments are applied directly to your dog's skin once a month and spread across their coat. Their active ingredients — permethrin and imidacloprid — are effective. But they come with their own concerns.

Permethrin is a synthetic insecticide the EPA classifies as "likely to be carcinogenic to humans" when ingested. It's also highly toxic to aquatic life, deadly to bees, and — critically for multi-pet households — potentially fatal to cats. Even indirect exposure through shared bedding or grooming can put a cat at serious risk. Dogs treated with permethrin-based topicals shouldn't swim in natural water for at least 48 hours post-application, as runoff can kill fish and aquatic invertebrates.

Reported side effects in dogs include skin irritation, trembling, muscle twitching, restlessness, and vomiting.

---

A Word About the Humans in the House

Most conversations about flea and tick product safety focus on the dog. But these ingredients don't stay neatly contained to one species.

Imidacloprid — present in both liquid topicals and the Seresto collar — has been linked to human exposure effects including skin rashes, numbness, facial swelling, lethargy, and nausea. In more serious poisoning cases: tremors, difficulty breathing, and disorientation. The EPA documented over 22,000 minor poisoning incidents in people from residential imidacloprid use between 1992 and 2009 — a significant portion from people who played with pets that had recently been treated.

One peer-reviewed study found that frequent prenatal exposure to imidacloprid through pet flea treatments was associated with an elevated risk of autism spectrum disorder in children — with odds ratios increasing to 2.0 among frequent users during pregnancy. The researchers noted the association warrants further investigation; this remains an area of active scientific interest, not settled science. But it's a signal that deserves attention — especially for families with pregnant women or young children in the home.

Flumethrin, one of the two active ingredients in the Seresto collar, has been linked to neurological issues in children including seizures and learning disabilities, according to the EPA's own analysis. Worth noting: the EPA's child safety assessment for the Seresto collar admitted it hadn't evaluated the combined effects of flumethrin and imidacloprid together — because the chemicals work through different mechanisms. That's a significant gap when children regularly cuddle and sleep next to dogs wearing these collars.

We're not sharing this to alarm you. We're sharing it because you deserve to know what the label doesn't say.

---

The Regulatory Picture: More Complicated Than You'd Think

It would be reassuring to believe that if something was dangerous, regulators would step in. The Seresto story is a lesson in why that assumption deserves scrutiny.

As early as 2015 — just three years after Seresto launched — an EPA internal investigation found the collar ranked first among similar products in incidents, major incidents, and deaths. Canada reviewed the same data and pulled the collar from shelves. Australia, Colombia, and the European Union required additional warning labels. The U.S. EPA allowed it to stay on the market with no additional restrictions for years.

The EPA's own scientists reportedly urged managers in internal emails to take action — but those concerns were not elevated. The 2024 Inspector General report confirmed that the EPA's oversight of Seresto was, in the words of one environmental health director, "absolutely abysmal."

The isoxazoline medications present a different kind of regulatory story. These are FDA-approved veterinary pharmaceuticals, and the FDA did eventually require updated label warnings after post-market data came in. But the process took years of real-world adverse event reports to generate action — which means pets were the data.

This isn't an indictment of every scientist and regulator working in this space. Many are doing their best. But it is a reason to ask questions, read labels carefully, and not assume that "approved" means "risk-free for everyone."

---

There's a Better Way

We started Sweet Natured Pet because we believed that protecting our animals shouldn't mean exposing them — or us — to a cocktail of synthetic pesticides and known neurotoxins.

Our No Bugs! Flea, Tick & Mosquito Repellent Spray is formulated with cedarwood oil (Virginia) and lemongrass oil as active ingredients — both on the EPA's list of minimum-risk pesticides under FIFRA Section 25(b). That means they're recognized as posing minimal risk to people, pets, and the environment. No isoxazolines. No imidacloprid. No permethrin. No synthetic neurotoxins. And yes — formulated to be safe around cats.

Is a plant-based repellent the right choice for every dog in every situation? That's a conversation worth having with your vet, especially if you're in a high Lyme disease area or dealing with a serious infestation. We believe in honest conversations, not hype.

But for everyday prevention — the kind that keeps fleas, ticks, and mosquitoes from turning your backyard into a threat — we think plants can do the job without the baggage.

Your dog trusts you to make the best call. Now you have a little more to work with.

 

Have questions about our formulation or ingredients? We love this stuff — reach out anytime. And if you found this post helpful, share it with a fellow pet parent who might be asking the same questions.

 

---

Sources & Further Reading

• U.S. FDA Animal Drug Safety Communication on Isoxazoline Products (2018)

• U.S. EPA Seresto Pet Collar Review

• EPA Office of Inspector General Report on Seresto (February 2024)

• U.S. House Subcommittee on Economic and Consumer Policy, Seresto Investigation Report (2022)

• NRDC Comments to EPA on Imidacloprid Health Risks

• Keil et al., "Autism Spectrum Disorder and Flea/Tick Medication," PMC3922790

• National Pesticide Information Center (NPIC) Fact Sheets: Permethrin, Imidacloprid

• Beyond Pesticides Daily News Blog

• Center for Biological Diversity, EPA Incident Data on Seresto